C-MER Medical Holdings Limited (Stock Code: 03309) released a Next Day Disclosure Return dated 11 November 2025, reporting a repurchase of 240,000 ordinary shares on 11 November 2025 at an average price of HKD 1.7981. Following this transaction, the company's issued shares (excluding treasury shares) stood at 1,240,032,870, while treasury shares totaled 15,528,000, keeping the overall figure at 1,255,560,870 shares.

According to the document, 23,218,000 shares were repurchased for cancellation on various dates from 12 July 2024 through 15 May 2025, with prices ranging approximately from HKD 1.3632 to HKD 2.64. These shares had not yet been cancelled as of the closing balance date of 11 November 2025. The total number of shares authorized for repurchase under the shareholder mandate dated 19 May 2025 stands at 125,556,087, representing 0.0194% of the shares in issue (excluding treasury shares) at the time the resolution was granted.

The repurchase mandate places a 30-day moratorium on new share issuances or the sale or transfer of any treasury shares, extending until 11 December 2025. The announcement confirms that all share repurchases were carried out in accordance with relevant listing rules without any material change from the Explanatory Statement dated 23 April 2025.